Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.
about
Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinomaThe Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging BiomarkersTherapy response with diffusion MRI: an updatePrognostication and response assessment in liver and pancreatic tumors: The new imagingDiffusion-weighted MR imaging of pancreatic cancer: A comparison of mono-exponential, bi-exponential and non-Gaussian kurtosis modelsPhase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinomaImaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoringDiffusion imaging for therapy response assessment of brain tumorRecent Advances in CT and MR Imaging for Evaluation of Hepatocellular CarcinomaImaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.Parametric exploration of the liver by magnetic resonance methodsDiffusion-weighted imaging of the liver: techniques and applications.Diffusion MRI in early cancer therapeutic response assessment.Technical advancements and protocol optimization of diffusion-weighted imaging (DWI) in liver.A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)Utility of diffusion-weighted imaging to assess hepatocellular carcinoma viability following transarterial chemoembolization.Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survivalTranscatheter arterial chemoembolization for infiltrative hepatocellular carcinoma: clinical safety and efficacy and factors influencing patient survivalDiffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolizationPredicting and monitoring cancer treatment response with diffusion-weighted MRI.Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinomaPathological and MR-DWI study of the acute hepatic injury model after stem cell transplantation.Volumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib.Quantitative proton MR spectroscopy as a biomarker of tumor necrosis in the rabbit VX2 liver tumor.Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumorFunctional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinomaMultimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.CT Perfusion Imaging Can Predict Patients' Survival and Early Response to Transarterial Chemo-Lipiodol Infusion for Liver Metastases from Colorectal CancersSequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignanciesNovel imaging biomarkers of response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients.Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomesIntraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoemboPhase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury.Semiautomatic volumetric tumor segmentation for hepatocellular carcinoma: comparison between C-arm cone beam computed tomography and MRI.Hepatocellular carcinoma: IVIM diffusion quantification for prediction of tumor necrosis compared to enhancement ratios.Role of quantitative magnetic resonance imaging parameters in the evaluation of treatment response in malignant tumors.
P2860
Q26745449-EF8876DB-D244-47E5-9F46-F7C44DE64B2BQ26768460-96FDD024-8069-467E-830E-FE1E378A8AD5Q26851700-8D059940-250B-4462-B265-6664B14B950EQ27021568-0D23A99A-4BC1-4161-8A08-E26C5F86B98DQ28073561-D4284A95-53A2-4B3C-BC73-D6D484D128B1Q28247867-C06FD4C8-C040-48C5-9D76-9B4B55B65881Q30436747-519AAE0F-42E2-46D6-B220-38FCC4B8B365Q30437277-C0FE8848-9AA1-4FF6-AB92-C7BBE4F1BB03Q30448049-363F9520-22B8-4712-9828-7022ECD86485Q30458257-4558AB06-D635-46A6-826A-3437569D7FA1Q30485888-88AC63D2-DD89-423F-B942-3DFD9029C451Q30840354-F34F51BF-6CCE-4652-85D9-AE3F379B0E55Q31037179-7710169F-3050-4E42-ACF8-A1FAB277712CQ31041796-32C6970B-60CE-4F4D-9FAC-C16B5622319FQ32173730-C0AC9618-AE82-47C8-948F-6DBA8FD472E6Q33843274-813BBF84-9CC7-4D8F-ADEB-2611E57A3328Q33925521-8A7AC0F0-012D-48DD-9291-26A63068EF5AQ33929310-079F9267-3434-4738-8F65-5C0C7DA53AD8Q33960387-E1050F15-B138-4E5A-9F0D-086139117697Q34052992-55BA277B-80DF-4FEC-925A-FD4F55D5DE49Q34681150-0A9586DB-9C4E-48BF-8609-900CC1CA43FAQ35061918-AB9A9ABA-A2B2-40CF-93FE-4D998C1C80ABQ35073497-BA3B21B6-1253-4E28-BEBC-EA995887C938Q35101056-5B5A5989-EFDB-44D9-96E1-4F447070C868Q35111997-82FDC5B5-6BBB-4E78-B2BF-6D81C696B348Q35163735-557D6657-B23B-4674-BB27-B80DE8EBB424Q35203257-DAD7B16E-8C1C-4FE4-B84A-FF31117D8385Q35732421-F6F46765-5283-42E2-A4B3-A6F706E8B9B0Q35843666-E40D4207-84A3-437F-A2FC-89523DBC2851Q36120986-9AA08B0E-95BB-4A6E-855D-353B9174EABFQ36419100-94F1679A-6CD3-4760-A6B0-CD188C413674Q36423114-6999C15E-325C-46E1-9506-77D9062FB195Q36512761-B6C294D4-D798-45EA-8CE1-DCCCBAE1E62EQ36573406-4D9DE7D9-5DDC-45AE-A7DD-C64057FD742AQ36625954-8B26FC6E-2265-48AF-AFA5-A246C8D4B78AQ36630342-F7623F84-D1D4-467A-86DC-87C4E46AE1EBQ36681218-CCB05428-A694-454F-AB7C-2A59D637AAFAQ36700219-648F07E2-64C9-4BCE-8BFB-7E47AF014110Q36740054-AAB07048-94F2-4D7C-A095-237EB318AC03Q36801476-B1571040-01E5-4737-A651-DBC0672EE6D7
P2860
Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Unresectable hepatocellular ca ...... n as detected with MR imaging.
@en
Unresectable hepatocellular ca ...... n as detected with MR imaging.
@nl
type
label
Unresectable hepatocellular ca ...... n as detected with MR imaging.
@en
Unresectable hepatocellular ca ...... n as detected with MR imaging.
@nl
prefLabel
Unresectable hepatocellular ca ...... n as detected with MR imaging.
@en
Unresectable hepatocellular ca ...... n as detected with MR imaging.
@nl
P2093
P1433
P1476
Unresectable hepatocellular ca ...... on as detected with MR imaging
@en
P2093
Diane K Reyes
Ihab R Kamel
Jean-François H Geschwind
Marianna Zahurak
P304
P356
10.1148/RADIOL.2502072222
P407
P577
2009-02-01T00:00:00Z